Discover details of the first randomized, multicenter Phase III study to compare the safety and efficacy of mirvetuximab soravtansine vs investigator’s choice of chemotherapy in women with folate receptor-α-positive, platinum-resistant epithelial ovarian, primary peritoneal or fallopian tube cancer.
Browsing: Taxonomy > Biological and targeted therapies
Results from a pair of clinical trials evaluating the CAR-T cell therapy Kymriah™ have demonstrated long-lasting remissions in non-Hodgkin’s lymphoma patients.
In this research article from the Journal of Comparative Effectiveness Research find out about the characteristics and treatment patterns among US patients with hairy cell leukemia.
Researchers at Cancer Research UK have discovered a potential combination treatment for glioblastoma, by exploiting leaks in the blood-brain barrier.
In this editorial from Future Oncology the authors explore tumor biology, host biology and patient’s quality of life in respect to circumvent hesitancy between CDK4/6 and mTOR inhibitors in second-line treatment of HR+, erb2- metastatic breast cancer.
Chris Lewis (Patient Advocate and Founder of Chris’s Cancer Community) discusses the treatment he underwent following his diagnosis with lymphoma in…
In this review find out about the controversy with regards to the technical details of portal vein embolization , periprocedural management and whether alternative methods of achieving future liver remnant hypertrophy are preferable.
Proper staging, early detection and accurate diagnosis all play a key role in successful treatment for cancer patients. Discover some of the treatment options for mesothelioma in this opinion piece.